Several widely prescribed medication classes can trigger burning mouth syndrome (BMS), with antidepressants (specifically SSRIs) and blood pressure drugs (specifically ACE inhibitors) being the most common culprits. About one-third of drug-induced BMS cases are dose-dependent, meaning the burning sensation appears or worsens after a dosage increase rather than when the medication is first started.
Drug-induced BMS is classified as “secondary” burning mouth syndrome, meaning it has an identifiable cause. This distinction matters because secondary BMS typically resolves once the triggering medication is adjusted or discontinued, unlike primary BMS, which has no known cause and is harder to treat.
SSRIs and Other Antidepressants
Selective serotonin reuptake inhibitors are among the most frequently reported medication triggers for burning mouth syndrome. Fluoxetine and sertraline are the two SSRIs most clearly linked to the condition in published case reports. In one well-documented case, a patient with major depression developed burning mouth symptoms after a dosage increase of their SSRI, and the burning completely resolved once the medication was stopped.
The irony is hard to miss: antidepressants are also one of the main treatments for primary BMS. The same drug class that relieves burning in some patients can cause it in others. This paradox makes diagnosis tricky, especially if someone is already taking an antidepressant when symptoms begin.
Beyond SSRIs, other psychotropic medications are commonly used by BMS patients. In a study of 80 BMS patients in Taiwan, 87.5% were taking some form of psychotropic medication. The breakdown included anxiolytics (31.3%), antidepressants (28.8%), sedatives and sleep aids (20%), and antipsychotics (7.5%). While not all of these necessarily caused the burning, the overlap between psychotropic use and BMS is striking.
ACE Inhibitors and Blood Pressure Drugs
ACE inhibitors, a common class of blood pressure medication, are the other major drug-induced trigger. Captopril, enalapril, and lisinopril have all been specifically named in reports of medication-induced BMS. These drugs are taken by millions of people for high blood pressure and heart failure, so even a small percentage of users developing oral burning translates to a significant number of affected patients.
Angiotensin receptor blockers (ARBs), which are closely related to ACE inhibitors, have also been linked to BMS, either alone or in combination with ACE inhibitors. Beta-blockers and calcium channel blockers round out the blood pressure medications associated with the condition, though the evidence for these is less robust than for ACE inhibitors.
Why These Two Drug Classes Share the Same Side Effect
SSRIs and ACE inhibitors seem like completely unrelated medications, but they converge on the same brain pathway. Both reduce the output of dopamine-producing neurons in a circuit called the basal ganglia dopamine loop, though they do it through different mechanisms. SSRIs raise serotonin levels, which indirectly suppresses dopamine signaling. ACE inhibitors interfere with the breakdown of a pain-signaling molecule called substance P, which also ends up reducing dopamine output through a separate route. The result is the same: less dopamine activity in a brain circuit involved in processing oral sensations, which appears to produce the characteristic burning feeling.
Benzodiazepines: A Paradoxical Trigger
Clonazepam presents another paradox in BMS. It is one of the most studied treatments for burning mouth symptoms, with clinical trials showing mild to moderate improvement. Yet it can also cause the condition. The first published case involved a 52-year-old woman who was switched from one benzodiazepine to clonazepam for anxiety and panic. After four weeks, she developed a constant oral burning sensation. Her doctor reduced the dose, which helped somewhat but not enough. When clonazepam was discontinued entirely, the burning resolved completely. She later asked to restart the medication because nothing else controlled her anxiety, but the burning returned, and it resolved again when she stopped.
This case scored as “highly probable” on a standard scale used to assess whether a drug caused a side effect, confirming the link wasn’t coincidental. While this reaction appears uncommon, it’s worth knowing about given how frequently benzodiazepines are prescribed.
Other Medications Linked to BMS
Several additional medications have been reported as triggers:
- Efavirenz, an antiviral used in HIV treatment
- Hormone replacement therapies, used during and after menopause
- Antihistamines and decongestants, which can severely dry the mouth
- Anticholinergic agents, found in medications for overactive bladder, certain antidepressants, and some allergy drugs
Medications for Parkinson’s disease, diabetes drugs, and cholesterol-lowering agents also appeared frequently among BMS patients in the Taiwanese study, though whether they directly cause burning or simply reflect the demographics of people who develop BMS (predominantly older adults on multiple medications) is harder to untangle.
Drug-Induced Dry Mouth vs. True Burning
Many of the medications on this list also cause dry mouth, and it’s important to understand that these are related but distinct problems. Dry mouth is a subjective feeling of insufficient saliva. When saliva production actually drops, people can develop difficulty eating, swallowing, and speaking, along with a chronic burning sensation and altered taste. So some cases of “drug-induced BMS” may really be severe dry mouth mimicking or contributing to burning symptoms rather than a direct neurological effect of the drug.
The distinction matters for treatment. If the burning is driven by dry mouth, saliva substitutes and hydration strategies can help. If it’s a direct effect of the medication on dopamine pathways in the brain, the only reliable fix is adjusting the medication itself.
How Drug-Induced BMS Is Identified
There’s no blood test or imaging scan that confirms drug-induced BMS. Diagnosis works by exclusion. A clinician will examine your mouth for visible abnormalities (there shouldn’t be any with true BMS), review your full medication list, and look for a timeline connection between starting or increasing a drug and the onset of burning. They’ll also rule out other causes like nutritional deficiencies, oral infections, allergies, and hormonal changes.
The strongest evidence that a medication is responsible comes from what happens when you stop taking it. In the published case reports, burning symptoms consistently resolved after the triggering drug was discontinued. If you suspect a medication is causing oral burning, your prescriber can help determine whether a dose reduction, a switch to a different drug in the same class, or discontinuation makes sense given your overall health needs. BMS affects roughly 1.73% of the general population, with women outnumbering men about three to one, and onset is most common in middle-aged and older adults around menopause.